G PROTEIN REGULATION OF CL SECRETION IN AIRWAY EPITHELIA
G PROTEIN REGULATION OF CL SECRETION IN AIRWAY EPITHELIA
批准号:
3247412
负责人:
Bruce A. Stanton
金额:
$19.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 1997-09-29
关键词:
G protein arachidonate biological signal transduction chloride channels chlorine confocal scanning microscopy cystic fibrosis human genetic material tag human tissue ion transport metabolism disorder chemotherapy northern blottings phospholipase A2 respiratory epithelium tissue /cell culture transfection voltage /patch clamp western blottings xanthines
中文摘要
囊性纤维化所致肺部疾病的发病机制
部分原因是囊性纤维化跨膜电导突变
一种cAMP刺激的氯离子通道(CFTR)。无能为力
CAMP刺激氯离子(CFtr)分泌和钠的增加
慢性阻塞性肺疾病患者的呼吸道重吸收有助于
呼吸道脱水与肺部疾病的发病机制有关。
最近有研究表明,钠离子通道的雾化疗法
阻滞剂阿米洛利改善粘液纤毛清除,减慢粘液纤毛清除速度
肺活量下降的原因。气雾剂疗法旨在纠正
慢性阻塞性肺疾病患者的氯离子分泌缺陷也可能对肺部有益
疾病。然而,一种有效的治疗方法来增加cAMP刺激的氯
慢性阻塞性肺疾病患者的呼吸道分泌物(CFTR)尚未被
已确认身份。这项研究提出的长期目标是
因此,应用是开发一种药理学方法来治疗
环磷腺苷激活氯离子通道(cAMP-激活型氯离子通道)
基于气雾剂的治疗。我们开发这种方法的战略是
根据我们的初步实验证明,异三聚体
G蛋白抑制人气管cAMP激活的氯离子通道
上皮细胞和A1使抑制性G蛋白失活
腺苷受体拮抗剂恢复氯环腺苷(CAMP)激活(CFTR)
频道。我们建议检验这一假说,腺苷,产生
并由呼吸道上皮细胞释放,激活A1腺苷
刺激抑制性G蛋白的受体。G蛋白,在
反过来,使cAMP激活的氯通道失活。磷酸化
蛋白激酶A介导的CL(CFTR)通道可解除G蛋白抑制
在正常情况下,但在CF细胞中不存在。我们的具体目标是:1)
用全细胞技术研究G蛋白对氯离子通道的调控
和单通道膜片钳技术。我们将鉴定G蛋白
Northern印迹和Western印迹分析及其细胞定位
通过共聚焦免疫细胞化学显微镜:2)阐明信号
涉及G蛋白对氯的调节的信号转导通路(CFTR)
采用全细胞和单通道膜片钳技术的通道。我们
将确定G蛋白是否通过磷脂酶抑制氯(CFTR)通道
A2和花生四烯酸,以及3)开发一种治疗方法,基于
用A1受体拮抗剂灭活抑制性G蛋白,以
膜片钳技术增加CF细胞的氯(CFtr)分泌
和测量氯在人体呼吸道单层中的传输
细胞。因为A1腺苷拮抗剂是无毒有效的
在Num浓度方面,A1拮抗剂是很有希望的候选者
慢性阻塞性肺疾病患者的雾化药物治疗我们预计我们的研究
将增加我们对信号通路调控的理解
CAMP激活的氯通道在呼吸道上皮细胞和
腺苷A1受体与G蛋白相互作用机制的研究
在调节氯(CFTR)通道中。最后,我们预计我们的
研究将导致开发一种基于气雾剂的治疗方法
刺激CF气道分泌氯离子(CFTR)。
英文摘要
The pathogenesis of lung disease induced by Cystic Fibrosis (CF) is due
in part to mutations in the cystic fibrosis transmembrane conductance
regulator (CFTR), a cAMP-stimulated Cl (CFTR) channel. The inability of
cAMP to stimulate Cl (CFTR) secretion and the increased rate of Na
reabsorption in the airway of patients with CF contributes to the
dehydration of the airway and to the pathogenesis of lung disease.
Recently, it was shown that aerosol therapy with the sodium channel
inhibitor amiloride improved mucociliary clearance and slowed the rate
of decline in lung vital capacity. Aerosol therapy designed to correct
defective Cl secretion in CF patients may also be beneficial for lung
disease. However, an effective treatment to increase CAMP-stimulated Cl
(CFTR) secretion by the airway of patients with CF has not been
identified. The long-term objective of the research proposed in this
application, therefore, is to develop a pharmacological approach to
stimulate CAMP-activated Cl (CFTR) channels in CF patients using
aerosol-based therapy. Our strategy to develop such an approach is
based on our preliminary experiments demonstrating that heterotrimeric
G proteins inhibit cAMP-activated Cl (CFTR) channels in human tracheal
epithelial cells and that inactivating inhibitory G proteins with A1
adenosine receptor antagonists restores cAMP-activation of Cl (CFTR)
channels. We propose to test the hypothesis that adenosine, produced
and released by airway epithelial cells, activates an A1 adenosine
receptor that stimulates inhibitory G proteins. The G proteins, in
turn, inactivate cAMP-activated Cl (CFTR) channels. Phosphorylation of
Cl (CFTR) channels by protein kinase A may relieve G protein inhibition
in normal but not in CF cells. Our specific aims are to: 1)
Characterize G protein regulation of Cl (CFTR) channels using whole-cell
and single channel patch clamp techniques. We will identify G proteins
by Northern blot and Western blot analysis and their cellular location
by confocal immunocytochemical microscopy: 2) Elucidate the signal
transduction pathways involving G protein regulation of Cl (CFTR)
channels using whole-cell and single channel patch clamp techniques. We
will determine if G proteins inhibit Cl(CFTR) channels via phospholipase
A2 and arachidonic acid and 3) Develop a therapeutic approach, based on
inactivating inhibitory G proteins with A1 receptor antagonists, to
increase Cl (CFTR) secretion by CF cells using patch clamp techniques
and measurements of Cl transport across monolayers of human airway
cells. Because A1 adenosine antagonists are nontoxic and are effective
in nuM concentrations, A1 antagonists are promising candidates for
aerosol pharmacotherapy for CF patients. We anticipate that our studies
will increase our understanding of the signalling pathways regulating
cAMP-activated Cl (CFTR) channels in airway epithelial cells and
elucidate the mechanism of A1 adenosine receptor-G protein interaction
in regulating Cl (CFTR) channels. Finally, we anticipate that our
studies will lead to the development of an aerosol-based treatment for
stimulating Cl (CFTR) secretion by CF airways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Let-7b in Extracellular Vesicles Secreted by Bronchial Epithelial Cells Increases the Antibiotic Sensitivity of Pseudomonas
-
批准号:10319005
-
项目类别:
-
资助金额:$53.94万
-
财政年份:2020
-
负责人:Bruce A. Stanton
-
依托单位:
Let-7b in Extracellular Vesicles Secreted by Bronchial Epithelial Cells Increases the Antibiotic Sensitivity of Pseudomonas
-
批准号:10525239
-
项目类别:
-
资助金额:$53.94万
-
财政年份:2020
-
负责人:Bruce A. Stanton
-
依托单位:
Retrieval, Reprocessing, Normalization and Sharing of Gene Expression and Lung Microbiome Data Sets to Facilitate AI/ML Analysis Studies of Bacterial Lung Infections
-
批准号:10594180
-
项目类别:
-
资助金额:$26.24万
-
财政年份:2020
-
负责人:Bruce A. Stanton
-
依托单位:
Gastrointestinal Biology Core
-
批准号:10001761
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2018
-
负责人:Bruce A. Stanton
-
依托单位:
CF Bioinformatics and Biostatistics Core
-
批准号:10001763
-
项目类别:
-
资助金额:$25.11万
-
财政年份:2018
-
负责人:Bruce A. Stanton
-
依托单位:
Gastrointestinal Biology Core
-
批准号:10686312
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2018
-
负责人:Bruce A. Stanton
-
依托单位:
CF Bioinformatics and Biostatistics Core
-
批准号:10686327
-
项目类别:
-
资助金额:$25.11万
-
财政年份:2018
-
负责人:Bruce A. Stanton
-
依托单位:
Gastrointestinal Biology Core
-
批准号:10241580
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2018
-
负责人:Bruce A. Stanton
-
依托单位:
CF Bioinformatics and Biostatistics Core
-
批准号:10241582
-
项目类别:
-
资助金额:$25.11万
-
财政年份:2018
-
负责人:Bruce A. Stanton
-
依托单位:
Arsenic and Innate Immunity in Human Lung
-
批准号:8881879
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2014
-
负责人:Bruce A. Stanton
-
依托单位:
Dartmouth Lung Biology Center for Molecular, Cellular and Translational Research
-
批准号:9115188
-
项目类别:
-
资助金额:$118.59万
-
财政年份:2013
-
负责人:Bruce A. Stanton
-
依托单位:
Dartmouth Lung Biology Center for Molecular, Cellular and Translational Research
-
批准号:8727639
-
项目类别:
-
资助金额:$120.07万
-
财政年份:2013
-
负责人:Bruce A. Stanton
-
依托单位:
Dartmouth Lung Biology Center for Molecular, Cellular and Translational Research
-
批准号:8514218
-
项目类别:
-
资助金额:$120.84万
-
财政年份:2013
-
负责人:Bruce A. Stanton
-
依托单位:
Dartmouth Lung Biology Center for Molecular, Cellular and Translational Research
-
批准号:8899599
-
项目类别:
-
资助金额:$119.32万
-
财政年份:2013
-
负责人:Bruce A. Stanton
-
依托单位:
COBRE: CELL BIOLOGY AND IMAGING CORE
-
批准号:8359700
-
项目类别:
-
资助金额:$22.36万
-
财政年份:2011
-
负责人:Bruce A. Stanton
-
依托单位:
COBRE: FACULTY DEVELOPMENT CORE
-
批准号:8359701
-
项目类别:
-
资助金额:$32.31万
-
财政年份:2011
-
负责人:Bruce A. Stanton
-
依托单位:
COBRE: ADMINISTRATIVE CORE
-
批准号:8359699
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2011
-
负责人:Bruce A. Stanton
-
依托单位:
COBRE: ADMINISTRATIVE CORE
-
批准号:8167467
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2010
-
负责人:Bruce A. Stanton
-
依托单位:
COBRE: FACULTY DEVELOPMENT CORE
-
批准号:8167469
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2010
-
负责人:Bruce A. Stanton
-
依托单位:
COBRE: CELL BIOLOGY AND IMAGING FACILITY CORE
-
批准号:8167468
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2010
-
负责人:Bruce A. Stanton
-
依托单位:
海外基金